Insider trade

Officer sold ~$2.84M of GILD shares in the open market

Traded Feb 17, 2026 · Filed Feb 18, 2026

~$2.84M
Reported value · 18K sh @ $154.182: 130K
Holds after · shares reported: -5.0%
stock since the trade · S&P 500 +11.9%, $155.27 → $147.50 on Oct 1

Why it stands out

Gilead Sciences's Chief Comm & Corp Aff Officer sold $2.84M of Gilead Sciences shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 17, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 18, 2026

Officer$1M+Pre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$2,837,720

Shares × reported transaction price

Timing vs results

7 days after results of Feb 10, 2026, 79 days before results of May 7, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $155.27 on Feb 17, 2026, within 1% of its 52-week high, after a 28% rise over the previous 30 trading days

52-week range $96.91 (May 9, 2025) to $155.80 (Feb 11, 2026), 99% of the way up, from 251 adjusted closes. 30 trading days earlier: $121.60 on Jan 2, 2026. Describes the past only, not a forecast

Layoff notice nearby

A WARN layoff notice covering 34 workers was filed in California on January 21, 2026.

From the official state WARN list, 27 days before the trade; 1 more notice by the company within 60 days. Shown for timing only; the two filings are separate

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	-4.9%	+0.7%	-5.6%
30 days	-9.1%	-4.3%	-4.9%
90 days	-13.5%	+8.3%	-21.8%
180 days	-5.1%	+12.1%	-17.2%

Past results only. Not a forecast.

Source receipt

Record ID: 0001782135-26-000006
Filed / recorded: Feb 18, 2026, 10:22 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: GILEAD SCIENCES, INC.
Issuer CIK: 882095
Ticker: GILD
Reporting person: Johanna Mercier
Relationship: Officer
Officer title: Chief Comm & Corp Aff Officer
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Feb 17, 2026
Transaction code: S
Shares / units: 18,405
Price per share: $154.182
Acquired / disposed: Disposed (D)
Shares owned after: 129,883
Ownership form: Direct
Amendment: No

Footnotes from the filing

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
Sale prices for the transactions reported range from $153.565 to $154.56 Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.